$MLYS

$27.28▲ -7.2% YTD

4 SEC 13D/G filings tracked · Last updated Sep 23, 2026

Filing History

MLYS ▼ -7.2% - Mineralys Therapeutics, Inc.

CP $27.28▲ -7.2%Sep 23, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Sc…

News

MLYS ▲ +1.2% - Mineralys Therapeutics, Inc.

CP $28.35▲ +1.2%Sep 21, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)…

News

MLYS ▼ -2.0% - Mineralys Therapeutics, Inc.

CP $30.50▲ -2.0%Sep 9, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)…

SEC 13D/G

MLYS - Mineralys Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$27.03▼ -24.24%Aug 6, 2026 · ThinkSabio Blog

$MLYS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MLYS Mineralys Therapeutics, Inc. : $27.03 Sector: Healthcare |…